Welcome to our dedicated page for Hasbro SEC filings (Ticker: HAS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From Nerf blasters to Magic: The Gathering booster packs, Hasbro’s business stretches far beyond toys. Its SEC disclosures unpack how a single brand portfolio fuels revenue across retail shelves, licensing deals, and Hollywood screens. If you have ever wondered where royalties from Dungeons & Dragons land in the income statement or how film production costs hit cash flow, this page assembles every document you need.
Stock Titan’s AI interprets each release, turning hundreds of pages into concise takeaways. The Hasbro quarterly earnings report 10-Q filing becomes a clear view of seasonal inventory swings; the Hasbro annual report 10-K simplified highlights long-term licensing contracts; and Hasbro 8-K material events explained surfaces real-time announcements about movie partnerships or leadership changes. Our platform delivers Hasbro insider trading Form 4 transactions and Hasbro Form 4 insider transactions real-time alerts, so you can see executive stock moves before the market digests them.
Whether you seek Hasbro proxy statement executive compensation to compare bonus structures, Hasbro earnings report filing analysis to track margin shifts in Wizards of the Coast, or simply want Hasbro SEC filings explained simply, Stock Titan provides the context. Use AI-powered summaries, instant search across every 10-K, 10-Q, 8-K, S-4, and Form 4, and download clean tables that make understanding Hasbro SEC documents with AI a straightforward step in your due-diligence process.
Rhythm Pharmaceuticals, Inc. (RYTM) � Form 4 insider filing
Director Camille L. Bedrosian reported the vesting of 4,000 restricted stock units (RSUs) on 18 June 2025 (transaction code M). Upon settlement, the RSUs converted into an equal number of common shares at no cash cost, increasing the director’s directly held common-stock position to 7,000 shares. No derivative securities remain outstanding from this grant, and no sales were disclosed. The filing was signed by attorney-in-fact Stephen Vander Stoep on 23 June 2025.
The transaction reflects routine equity compensation vesting rather than discretionary open-market buying or selling. Given the modest share count and automatic nature of the conversion, the event is considered immaterial to the company’s overall share structure and does not signal a change in strategic outlook or insider sentiment.
On 30 June 2025, Group President Todd Burrowes filed a Form 4 reporting an option exercise and immediate sale of Darden Restaurants (DRI) shares. He exercised 13,569 stock-option shares at an exercise price of $78.84 and sold the same number at a weighted-average price of $216.4493, realising an estimated pre-tax gain of about $1.9 million. The option, originally granted in July 2020 and fully vested by July 2024, now has zero remaining balance. Following the transaction, Burrowes still directly owns 46,326.616 shares, partly accumulated through the Employee Stock Purchase Plan and its dividend-reinvestment feature. No Rule 10b5-1 trading plan was noted. The filing represents routine insider portfolio management and is not expected to have a material impact on Darden’s operations or capital structure.